{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:29:27Z","timestamp":1794475767574,"version":"4.9.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016104","name":"Key Project of Research and Development Plan of Hunan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016104","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.vaccine.2026.128681","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T19:15:04Z","timestamp":1778267704000},"page":"128681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A novel subunit vaccine based on glycoprotein H and glycoprotein L fusion against pseudorabies virus infection"],"prefix":"10.1016","volume":"84","author":[{"given":"Xiaohang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZeZhong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renke","family":"Qing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinglong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2026.128681_bb0005","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s12250-020-00340-0","article-title":"Current status and challenge of pseudorabies virus infection in China","volume":"36","author":"Tan","year":"2021","journal-title":"Virol Sin"},{"key":"10.1016\/j.vaccine.2026.128681_bb0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.vetmic.2015.12.008","article-title":"Control of swine pseudorabies in China: opportunities and limitations","volume":"183","author":"Sun","year":"2016","journal-title":"Vet Microbiol"},{"issue":"14","key":"10.1016\/j.vaccine.2026.128681_bb0015","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/vr.144.14.365","article-title":"Eradication of Aujeszky\u2019s disease from New Zealand pig herds 1976-1997","volume":"144","author":"Pannett","year":"1999","journal-title":"Vet Rec"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128681_bb0020","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00705-011-1080-2","article-title":"Pseudorabies virus in wild swine: a global perspective","volume":"156","author":"Muller","year":"2011","journal-title":"Arch Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128681_bb0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13567-022-01063-8","article-title":"Bartha-K61 vaccine protects nursery pigs against challenge with novel european and asian strains of suid herpesvirus 1","volume":"53","author":"Papageorgiou","year":"2022","journal-title":"Vet Res"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128681_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/v15020370","article-title":"Recombinant pseudorabies virus usage in vaccine development against swine infectious disease","volume":"15","author":"Zhou","year":"2023","journal-title":"Viruses-Basel"},{"key":"10.1016\/j.vaccine.2026.128681_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.965997","article-title":"Efficacy of a gB + gD-based subunit vaccine and the adjuvant granulocyte-macrophage colony stimulating factor for pseudorabies virus in rabbits","volume":"13","author":"Cao","year":"2022","journal-title":"Front Microbiol"},{"issue":"39","key":"10.1016\/j.vaccine.2026.128681_bb0040","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1016\/j.vaccine.2020.07.025","article-title":"A single dose glycoprotein D-based subunit vaccine against pseudorabies virus infection","volume":"38","author":"Zhang","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128681_bb0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.virol.2019.07.027","article-title":"Fusion of pseudorabies virus glycoproteins to IgG fc enhances protective immunity against pseudorabies virus","volume":"536","author":"Li","year":"2019","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2026.128681_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1288458","article-title":"Pseudorabies gD protein protects mice and piglets against lethal doses of pseudorabies virus","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2026.128681_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2023.109799","article-title":"A self-assembled nanoparticle vaccine based on pseudorabies virus glycoprotein D induces potent protective immunity against pseudorabies virus infection","volume":"284","author":"Ren","year":"2023","journal-title":"Vet Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128681_bb0060","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1128\/JVI.73.4.3014-3022.1999","article-title":"Glycoprotein gL-independent infectivity of pseudorabies virus is mediated by a gD-gH fusion protein","volume":"73","author":"Klupp","year":"1999","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128681_bb0065","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00557-21","article-title":"In vitro viral evolution identifies a critical residue in the Alphaherpesvirus fusion glycoprotein B Ectodomain that controls gH\/gL-independent entry","volume":"12","author":"Vallbracht","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2026.128681_bb0070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.21775\/cimb.041.063","article-title":"Entry of Alphaherpesviruses","volume":"41","author":"Cairns","year":"2021","journal-title":"Curr Issues Mol Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128681_bb0075","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3390\/v14020296","article-title":"Well put together-a guide to accessorizing with the herpesvirus gH\/gL complexes","volume":"14","author":"Gonzalez-Del","year":"2022","journal-title":"Viruses-Basel"},{"issue":"19","key":"10.1016\/j.vaccine.2026.128681_bb0080","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1073\/pnas.1501176112","article-title":"A site of varicella-zoster virus vulnerability identified by structural studies of neutralizing antibodies bound to the glycoprotein complex gHgL","volume":"112","author":"Xing","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128681_bb0085","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/JVI.02561-12","article-title":"Human anti-varicella-zoster virus (VZV) recombinant monoclonal antibody produced after Zostavax immunization recognizes the gH\/gL complex and neutralizes VZV infection","volume":"87","author":"Birlea","year":"2013","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128681_bb0090","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.vaccine.2012.12.009","article-title":"Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies","volume":"31","author":"Loomis","year":"2013","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128681_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2022.10.003","article-title":"Epstein-Barr virus gH\/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition","volume":"55","author":"Chen","year":"2022","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128681_bb0100","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3390\/v14030541","article-title":"Antibodies targeting KSHV gH\/gL reveal distinct neutralization mechanisms","volume":"14","author":"Fricke","year":"2022","journal-title":"Viruses-Basel"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128681_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1135(97)00201-0","article-title":"Study of the protective immunity of co-expressed glycoprotein H and L of equine herpesvirus-1 in a murine intranasal infection model","volume":"60","author":"Kukreja","year":"1998","journal-title":"Vet Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128681_bb0110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/JVI.72.1.65-72.1998","article-title":"The gH-gL complex of herpes simplex virus (HSV) stimulates neutralizing antibody and protects mice against HSV type 1 challenge","volume":"72","author":"Peng","year":"1998","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128681_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008609","article-title":"Tetrameric glycoprotein complex gH\/gL\/gQ1\/gQ2 is a promising vaccine candidate for human herpesvirus 6B","volume":"16","author":"Wang","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2026.128681_bb0120","article-title":"Recombinant protein expression for structural biology in HEK 293F suspension cells: a novel and accessible approach","volume":"92","author":"Portolano","year":"2014","journal-title":"J Vis Exp"},{"key":"10.1016\/j.vaccine.2026.128681_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2019.108403","article-title":"Commercial E2 subunit vaccine provides full protection to pigs against lethal challenge with 4 strains of classical swine fever virus genotype 2","volume":"237","author":"Gong","year":"2019","journal-title":"Vet Microbiol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2026.128681_bb0130","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.vetimm.2012.09.001","article-title":"Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) cap and rep proteins after vaccination with a commercial PCV2 sub-unit vaccine","volume":"150","author":"Fort","year":"2012","journal-title":"Vet Immunol Immunopathol"},{"issue":"Suppl. 4","key":"10.1016\/j.vaccine.2026.128681_bb0135","doi-asserted-by":"crossref","first-page":"D90","DOI":"10.1016\/j.vaccine.2009.08.039","article-title":"Foot and mouth disease virus vaccines","volume":"27","author":"Rodriguez","year":"2009","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128681_bb0140","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1128\/jvi.71.10.7687-7695.1997","article-title":"Pseudorabies virus glycoprotein L is necessary for virus infectivity but dispensable for virion localization of glycoprotein H","volume":"71","author":"Klupp","year":"1997","journal-title":"J Virol"},{"issue":"Pt 10","key":"10.1016\/j.vaccine.2026.128681_bb0145","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1107\/S0907444906029799","article-title":"A time- and cost-efficient system for high-level protein production in mammalian cells","volume":"62","author":"Aricescu","year":"2006","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128681_bb0150","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00084-18","article-title":"Functional role of N-linked glycosylation in pseudorabies virus glycoprotein gH","volume":"92","author":"Vallbracht","year":"2018","journal-title":"J Virol"},{"issue":"33","key":"10.1016\/j.vaccine.2026.128681_bb0155","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1016\/j.vaccine.2013.05.078","article-title":"Montanide ISA\u2122 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle","volume":"31","author":"Dar","year":"2013","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.vaccine.2026.128681_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.06.022","article-title":"Superior protection against paratuberculosis by a heterologous prime-boost immunization in a murine model","volume":"42","author":"Colombatti Olivieri","year":"2024","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128681_bb0165","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1089\/vim.2014.0149","article-title":"A new adjuvant combined with inactivated influenza enhances specific CD8 T cell response in mice and decreases symptoms in swine upon challenge","volume":"28","author":"Bouguyon","year":"2015","journal-title":"Viral Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128681_bb0170","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/vaccines4020015","article-title":"Coupling peptide antigens to virus-like particles or to protein carriers influences the Th1\/Th2 polarity of the resulting immune response","volume":"4","author":"Pomwised","year":"2016","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128681_bb0175","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12985-022-01748-8","article-title":"Construction of a quadruple gene-deleted vaccine confers complete protective immunity against emerging PRV variant challenge in piglets","volume":"19","author":"Sun","year":"2022","journal-title":"Virol J"},{"issue":"18","key":"10.1016\/j.vaccine.2026.128681_bb0180","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1016\/j.vaccine.2024.04.092","article-title":"Virus-like particle-based multipathogen vaccine of FMD and SVA elicits balanced and broad protective efficacy in mice and pigs","volume":"42","author":"Song","year":"2024","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128681_bb0185","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1365-2567.1998.00423.x","article-title":"Low antigen dose favours selection of somatic mutants with hallmarks of antibody affinity maturation","volume":"93","author":"Gonz\u00e1lez-Fern\u00e1ndez","year":"1998","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2026.128681_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.776933","article-title":"Increased B cell selection stringency in germinal centers can explain improved COVID-19 vaccine efficacies with low dose prime or delayed boost","volume":"12","author":"Garg","year":"2021","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128681_bb0195","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1292\/jvms.55.913","article-title":"Mechanism of pruritus and peracute death in mice induced by pseudorabies virus (PRV) infection","volume":"55","author":"Takahashi","year":"1993","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.vaccine.2026.128681_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.976220","article-title":"Protective efficacy of intranasal inactivated pseudorabies vaccine is improved by combination adjuvant in mice","volume":"13","author":"Hua","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2026.128681_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.1036161","article-title":"A single dose of Astragalus saponins adjuvanted inactivated vaccine for pseudorabies virus protected mice against lethal challenge","volume":"9","author":"Chang","year":"2022","journal-title":"Front Vet Sci"},{"issue":"14","key":"10.1016\/j.vaccine.2026.128681_bb0210","article-title":"Piceatannol as an antiviral inhibitor of PRV infection in vitro and in vivo","volume":"13","author":"Wang","year":"2023","journal-title":"Animals-Basel"},{"key":"10.1016\/j.vaccine.2026.128681_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.1090398","article-title":"Antiviral activity of dandelion aqueous extract against pseudorabies virus both in vitro and in vivo","volume":"9","author":"Cai","year":"2023","journal-title":"Front Vet Sci"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26004895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26004895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:59:24Z","timestamp":1794473964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26004895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":43,"alternative-id":["S0264410X26004895"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128681","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel subunit vaccine based on glycoprotein H and glycoprotein L fusion against pseudorabies virus infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128681","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128681"}}